Jonathan Grinstein
North American Editor at Inside Precision Medicine
Scientist turned storyteller. North American Editor @inside_pm. for story leads: [email protected]
Articles
-
1 week ago |
insideprecisionmedicine.com | Jonathan Grinstein
After years of steadily advancing his career as an investment director in the European life sciences, Roman Kniazev took the bold but necessary step to begin navigating the turbulent biotech innovation landscape. “I realized that until you truly experience the agony of being a biotech entrepreneur, you cannot make wise investments,” Kniazev told Inside Precision Medicine.
-
2 weeks ago |
insideprecisionmedicine.com | Jonathan Grinstein
Drug development platforms are always spawning in the endless fight for superiority—there is always a bigger fish with more, for example, throughput or training data. Once in a while, a novel platform class is born, and that’s what Hanadie Yousef, PhD, has done by introducing the world’s first AI-enabled screening platform focused on mapping secreted proteins. This isn’t a bigger fish—it’s an entirely new ecosystem.
-
2 weeks ago |
insideprecisionmedicine.com | Jonathan Grinstein
Jonathan D. Grinstein, PhD, the North American Editor of Inside Precision Medicine, hosts a new series called Behind the Breakthroughs that features the people shaping the future of medicine. With each episode, Jonathan gives listeners access to their motivational tales and visions for this emerging, game-changing field. In May of 2020, drug developer Michelle Werner learned that one of her three children, her middle child Caffrey, was diagnosed with Duchenne muscular dystrophy (DMD).
-
2 weeks ago |
insideprecisionmedicine.com | Jonathan Grinstein
Jonathan D. Grinstein, PhD, the North American Editor of Inside Precision Medicine, hosts a new series called Behind the Breakthroughs that features the people shaping the future of medicine. With each episode, Jonathan gives listeners access to their motivational tales and visions for this emerging, game-changing field. In May of 2020, drug developer Michelle Werner learned that one of her three children, her middle child Caffrey, was diagnosed with Duchenne muscular dystrophy (DMD).
-
2 weeks ago |
insideprecisionmedicine.com | Jonathan Grinstein
For cervical cancer patients, the post-treatment phase isn’t the finish line; it’s the start of a new chapter of careful observation. Even after a taxing therapeutic battle, enduring chemotherapy and radiation, and feeling the immense relief of treatment’s end, patients return for vital examinations every three to six months for traces of recurrence. Lurking beneath the surface of that relief is the persistent question: Is the cancer truly gone?
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 460
- Tweets
- 442
- DMs Open
- Yes
“I’m overwhelmed to see the pictures of KJ at home, with his family,” Kiran Musunuru MD, PhD, told @Inside_PM. “…it just increases my determination to find ways to do the same for as many kids as possible.” @ChildrensPhila @DanaherCorp https://t.co/1iHPPuH4D6
Put Patrick Hsu (@pdhsu | @arcinstitute), Serge Saxonov (@10xGenomics), and Gilad Almogy (@UltimaGenomics) under the same roof to chat about the “virtual cell”…chances are they’ll say a thing or two that’ll make your mind explode. @Inside_PM, @sagepub https://t.co/WHuUTVNSCs
Discover how @AllofUsCEO Josh Denny, MD, is harnessing diverse biological data to advance understanding of health disparities, rare diseases, and common conditions in this Behind the Breakthroughs episode by @Inside_PM [@sagepub]. @NIH @AllofUsResearch https://t.co/tVz5nRVVPc